Bone Biologics Corp (BBLG) Financials

$0.54

$0.00 (-0.02%)

As on 15-Sep-2026 16:19EDT

Market cap

$2 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	3.06	3.23	4.22	9.43	3.67	1.10
Operating Profit (EBIT)	-3.06	-3.23	-4.22	-9.43	-3.67	-1.10
Other Income	--	--	--	--	--	--
Profit before Tax	-2.89	-3.11	-4.11	-8.95	-1.48	-1.61
Provision for Tax	--	--	-7.32	-2.18	-2.18	0.00
Profit after Tax (Net Income)	-2.89	-3.11	-4.11	-8.95	-1.48	-1.61
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-1.61

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	3.92	5.38	3.48	2.91	5.95	6.58
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	0.00	0.00	0.10
Current Liabilities	0.51	0.42	0.38	0.83	2.55	0.10
Total Liabilities	4.95	5.80	3.86	3.74	8.50	6.68

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	--	--	--	--	--	--
Current Assets	4.44	5.80	3.86	3.74	8.50	6.68
Total Assets	4.95	5.80	3.86	3.74	8.50	6.68
Total Debt*	--	--	--	--	--	--
Net Current Assets	3.92	5.38	3.48	2.91	5.95	6.58

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-2.69	-4.12	-9.56	-3.57	-1.23
Cash Flow from Investing Activities	--	--	--	--	--	--
Cash from Financing Activities	--	4.70	4.42	5.04	4.43	7.90
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.81	-2.65	-1.39	-19.50	-23.27	-37.37
Cash EPS ($)	--	-2.65	-1.39	-19.50	-23.27	-37.37
Adjusted Book Value ($)	--	4.58	1.18	6.33	93.22	152.56
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.29	-1.40	-20.82	-55.91	-28.51
Free Cash Flow per Share ($)	--	-2.29	-1.40	-20.82	-55.91	-28.51

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-70.17	-128.70	-202.15	-23.71	-69.94
ROE (%)	-62.16	-70.17	-128.70	-202.15	-23.71	45.26
ROA (%)	-46.79	-64.38	-108.22	-146.31	-19.57	-48.26
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	68.24	--	54.05	-11.00	-631.93	-33.51
Net Profit Growth (%)	31.50	24.39	54.05	-502.78	7.83	11.73
EPS Growth (%)	32.89	-0.90	0.93	0.16	0.38	-627.40
Book Value Growth (%)	-81.53	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.55	-0.68	-0.23	-0.01	-0.09
Price / Book Value	0.39	0.32	0.80	0.71	0.00	0.02
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.13	1.17	-5.11	-1.98	9.99	8.11
Close Price ($)	1.37	1.45	5.64	27.12	301.97	5,068.80
High Price ($)	4.00	7.74	38.04	576.00	9,763.06	21,600.29
Low Price ($)	1.07	1.31	4.80	17.46	255.89	4,651.20
Market Cap ($ Cr)	1.52	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	-0.27	0.13	--
Current Ratio	8.67	13.85	10.22	4.50	3.33	66.81
Quick Ratio	8.67	--	--	5.19	3.56	--
Interest Coverage	--	--	--	-4.10	-11.02	-1.37

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.